Education
About Us
Working with TipRanks
Follow Us
Aroa Biosurgery Ltd (AU:ARX)
ASX:ARX
RESEARCH TOOLSreports
ARX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.41 - AU$0.82
Previous CloseN/A
Volume195.72K
Average Volume (3M)182.90K
Market Cap
AU$151.76M
Enterprise ValueAU$179.06M
Total Cash (Recent Filing)AU$10.68M
Total Debt (Recent Filing)AU$5.96M
Price to Earnings (P/E)―
Beta0.20
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding344,900,270
10 Day Avg. Volume218,383
30 Day Avg. Volume182,897
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.84
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.84Price Target Upside90.91% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Aroa Biosurgery Ltd News
PremiumCompany Announcements
Aroa Biosurgery Achieves Positive Cash Flow and Strengthens Market Position
PremiumCompany Announcements
Aroa Biosurgery Issues New Equity as Part of Employee Incentive Scheme
PremiumCompany Announcements
Aroa Biosurgery’s Myriad Shows Promise in Cost-Effective Limb Reconstruction
PremiumCompany Announcements
Aroa Biosurgery Unveils Half-Year Insights
PremiumCompany Announcements
Aroa Biosurgery Reports Strong Sales Growth in 2025
PremiumCompany Announcements
Aroa Biosurgery Sees Revenue Growth Amid Reduced Losses---
Options Prices
Currently, No data available
---
Ownership Overview
0.42% Insiders
0.05%
Mutual Funds
― Other Institutional Investors
99.53% Public Companies and
Individual Investors
ARX FAQ
What was Aroa Biosurgery Ltd’s price range in the past 12 months?
Aroa Biosurgery Ltd lowest share price was AU$0.41 and its highest was AU$0.81 in the past 12 months.
What is Aroa Biosurgery Ltd’s market cap?
Aroa Biosurgery Ltd’s market cap is AU$151.76M.
When is Aroa Biosurgery Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aroa Biosurgery Ltd’s earnings last quarter?
Aroa Biosurgery Ltd released its earnings results on May 20, 2024. The company reported -AU$0.011 earnings per share for the quarter, missing the consensus estimate of -AU$0.003 by -AU$0.008.
Is Aroa Biosurgery Ltd overvalued?
According to Wall Street analysts Aroa Biosurgery Ltd’s price is currently Undervalued.
Does Aroa Biosurgery Ltd pay dividends?
Aroa Biosurgery Ltd does not currently pay dividends.
What is Aroa Biosurgery Ltd’s EPS estimate?
Aroa Biosurgery Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aroa Biosurgery Ltd have?
Aroa Biosurgery Ltd has 344,900,270 shares outstanding.
What happened to Aroa Biosurgery Ltd’s price movement after its last earnings report?
Aroa Biosurgery Ltd reported an EPS of -AU$0.011 in its last earnings report, missing expectations of -AU$0.003. Following the earnings report the stock price went up 3.077%.
Which hedge fund is a major shareholder of Aroa Biosurgery Ltd?
Currently, no hedge funds are holding shares in AU:ARX
---
Aroa Biosurgery Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.84 (90.91% Upside)
AU$0.84 (90.91% Upside)
Blogger Sentiment
Bullish
AU:ARX Sentiment 100%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.72%
12-Months-Change
Fundamentals
Return on Equity
-8.04%
Trailing 12-Months
Asset Growth
-7.52%
Trailing 12-Months
Company Description
Aroa Biosurgery Ltd
Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and distributing medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. The company's products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction. Aroa Biosurgery Limited was incorporated in 2007 and is headquartered in Auckland, New Zealand.
---
ARX Stock 12 Month Forecast
Average Price Target
AU$0.84
▲(90.91% Upside)
Technical Analysis
Cochlear Limited
―
CSL
―
Fisher & Paykel Healthcare Corporation Limited
―
Nanosonics Limited
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
Best Analysts Covering ARX
1 Year
1 Year Success Rate
4/18 ratings generated profit
1 Year Average Return
-16.06%
reiterated a buy rating 2 months ago
Copying Shane Storey's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -16.06% per trade.
---